Review



polyclonal antibody targeting rap2a  (Novus Biologicals)


Bioz Verified Symbol Novus Biologicals is a verified supplier
Bioz Manufacturer Symbol Novus Biologicals manufactures this product  
  • Logo
  • About
  • News
  • Press Release
  • Team
  • Advisors
  • Partners
  • Contact
  • Bioz Stars
  • Bioz vStars
  • 85

    Structured Review

    Novus Biologicals polyclonal antibody targeting rap2a
    Table 2
    Polyclonal Antibody Targeting Rap2a, supplied by Novus Biologicals, used in various techniques. Bioz Stars score: 85/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/polyclonal antibody targeting rap2a/product/Novus Biologicals
    Average 85 stars, based on 1 article reviews
    polyclonal antibody targeting rap2a - by Bioz Stars, 2026-06
    85/100 stars

    Images

    1) Product Images from "The prognostic impact of RAP2A expression in patients with early and locoregionally advanced nasopharyngeal carcinoma in an endemic area"

    Article Title: The prognostic impact of RAP2A expression in patients with early and locoregionally advanced nasopharyngeal carcinoma in an endemic area

    Journal: American Journal of Translational Research

    doi:

    Table 2
    Figure Legend Snippet: Table 2

    Techniques Used: Expressing



    Similar Products

    85
    Novus Biologicals polyclonal antibody targeting rap2a
    Table 2
    Polyclonal Antibody Targeting Rap2a, supplied by Novus Biologicals, used in various techniques. Bioz Stars score: 85/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/polyclonal antibody targeting rap2a/product/Novus Biologicals
    Average 85 stars, based on 1 article reviews
    polyclonal antibody targeting rap2a - by Bioz Stars, 2026-06
    85/100 stars
      Buy from Supplier

    Image Search Results


    Table 2

    Journal: American Journal of Translational Research

    Article Title: The prognostic impact of RAP2A expression in patients with early and locoregionally advanced nasopharyngeal carcinoma in an endemic area

    doi:

    Figure Lengend Snippet: Table 2

    Article Snippet: Slides were washed with Tris buffered saline for 15 min and then incubated with a primary polyclonal antibody targeting RAP2A (1:250; Novus Biologicals, Cat No. NBP2-24574, LLC, CO) for one hour.

    Techniques: Expressing